Genetic testing for LQTS primarily involves panel testing for genes with strong and definitive evidence of causality in familial LQTS (see Table 7) and a gene with a moderate level of evidence for the development of the disease, CACNA1C (locus 12p13.3; L-type calcium channel) (ClinGen). Here, CACNA1C is linked to familial long QT syndrome.